Table 2 Observed malignant cancer cases by disease and period of observation (%)
From: Time trends of cancer incidence in childhood in Campania region: 25 years of observation
Disease | 1990–1994 | 1995–1999 | 2000–2004 | 2005–2009 | 2010–2014 |
|---|---|---|---|---|---|
ALL | 210 (20.5) | 193 (18.8) | 205 (20.0) | 199 (19.4) | 217 (21.1) |
LA hybrid/undiff. | 6 (50.0) | 4 (33.3) | 1 (8.3) | 1 (8.3) | 0 |
ANLL | 39 (17.7) | 42 (19.0) | 40 (18.1) | 50 (22.7) | 49 (22.2) |
MCL | 5 (20.8) | 3 (12.5) | 3 (12.5) | 4 (16.6) | 9 (37.5) |
NHL | 52 (18.5) | 63 (22.4) | 59 (20.9) | 61 (21.7) | 46 (16.3) |
HL | 16 (8.4) | 35 (18.5) | 35 (18.5) | 41 (21.6) | 62 (32.8) |
Neuroblastoma | 75 (21.9) | 58 (16.9) | 67 (19.5) | 72 (21) | 70 (20.4) |
CNS Tumour | 31 (6.2) | 78 (15.6) | 118 (23.6) | 122 (24.4) | 151 (30.5) |
Kidney Tumour | 44 (21.7) | 45 (22.2) | 29 (14.3) | 39 (19.3) | 45 (22.2) |
Soft tissue sarcoma | 31 (14.6) | 44 (20.7) | 45 (21.2) | 56 (26.4) | 36 (16.9) |
Histiocytosis | 25 (14.8) | 27 (16.0) | 33 (19.6) | 47 (27.9) | 36 (21.4) |
GCT | 15 (14.0) | 18 (16.8) | 12 (11.2) | 29 (27.1) | 33 (30.8) |
S. Ewing/PNET | 14 (12.8) | 20 (18.3) | 22 (20.1) | 22 (20.1) | 31 (28.4) |
Retinoblastoma | 16 (20.7) | 9 (11.6) | 22 (28.5) | 20 (25.9) | 10 (12.9) |
Bone Tumour | 16 (25.3) | 12 (19.0) | 8 (12.6) | 14 (22.2) | 13 (20.6) |
Liver Tumour | 6 (13.3) | 12 (26.6) | 9 (20.0) | 8 (17.7) | 10 (22.2) |
Nasofaryngeal carcinoma | 3 (33.3) | 1 (11.1) | 2 (22.2) | 2 (22.2) | 1 (11.1) |
Adrenocortical carcinoma | 3 (27.2) | 2 (18.1) | 3 (27.2) | 0 | 3 (27.2) |
Other Tumours | 4 (6.6) | 7 (11.6) | 13 (21.6) | 19 (31.6) | 17 (28.3) |
Total | 611 (16.7) | 673 (18.4) | 726 (19.8) | 806 (22) | 839 (22.9) |